	Zinsaufwendungen Für Schuld		Datum
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Agios Pharmaceuticals	USD 1.39B	85.53M	2025-09
Akebia Therapeutics	364.15M	18.56M	2025-09
Alnylam Pharmaceuticals	USD 44.4M	4.15M	2025-09
Anika Therapeutics	189.44M	1.76M	2025-09
Arrowhead Research	USD 22.5M	811K	2025-12
AstraZeneca	USD 484M	181M	2025-12
Bristol-Myers Squibb	USD 432M	48M	2025-12
Eli Lilly	USD 114.7M	134.3M	2025-09
Enanta Pharmaceuticals	USD 1.96M	620K	2024-12
Esperion Therapeutics	USD 15.08M	1.36M	2024-09
Halozyme Therapeutics	USD 4.3M	98K	2025-09
Heron Therapeutics	USD 500K	900K	2024-09
Insmed	USD 20.38M	863K	2025-09
J&J	USD 18M	290M	2025-09
Lexicon Pharmaceuticals	USD 2.21M	2.74M	2024-06
Ligand Pharmaceuticals	USD 910K	243K	2025-09
Merck	USD 412M	85M	2025-12
Minerva Neurosciences	USD 2.31M	60K	2024-06
Moderna	USD 12.14B	12.13B	2025-09
Novartis	USD 281M	8M	2025-09
Pfizer	USD 711M	59M	2025-12
PTC Therapeutics	USD 2.64B	2.61B	2025-09
Puma Biotechnology	USD 3.37M	11K	2024-06
Sangamo BioSciences	97.56M	11.39M	2025-06
Sanofi	EUR -25M	252M	2025-12
Takeda	JPY 123.63B	40.49B	2025-12
Teva Pharmaceutical Industries	USD 220M	17M	2025-12
Ultragenyx Pharmaceutical	USD 14.15M	108K	2025-09
Vanda Pharmaceuticals	601.14M	23.61M	2025-09
Veracyte	USD 2K	1000	2023-12

Vanda Pharmaceuticals Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.